Category: Parry
-
Perimeter Medical Imaging AI (PINK.V) isn’t messing about: Let’s make breast cancer treatment better – and profitable!
In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to trial’, and a lot of ‘billion dollar industry’ talk. Lots of early stage bets, a little over-hype perhaps. For the most part, you’re being asked to invest in technologies that…
-
Aequus Pharmaceuticals (AQS.V) gets Health Canada device licence approval, validates business model
Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced another win Monday morning with news Health Canada has approved the advancing of their Evolve dry-eye relief gel line to an easy-squeeze eye drop bottle. Admittedly,…
-
![FansUnite (FANS.C) agrees e-sports data supply deal with online betting platform]()
FansUnite (FANS.C) agrees e-sports data supply deal with online betting platform
Just a few months since announcing they were merging with Askott Entertainment, a deal that brought casino gaming and daily fantasy sports access to FansUnite’s (FANS.C) sports betting platform, FANS has announced another partnership, this time with Pinnacle Solutions, an award-winning online B2B e-sports betting platform. The deal will add Pinnacle’s e-sports data and odds…
-
Watch me: I can sell you on CLS Holdings (CLSH.C), with its one dispensary, being a better buy than Trulieve (TRUL.C), with 52
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for the cannabis crowd, and a rough last year for everyone else. With Aurora Cannabis (ACB.T) losing the gross national product of Panama, Chuck Rifici bailing from…
-
Tick-tock: Tocvan Ventures (TOC.C) quietly doing the work as it proves out an intriguing gold resource
When we first talked about Tocvan Ventures (TOC.C) back in June, it was selling for around $0.15 and nobody was really talking about it. In certain markets, hype is rewarded hard, but there’s something to be said for a deal in which what’s being said is the very essence of non-hype – and the stock…
-
Adults in the room alert: Kwesst (KWE.V) develops and sells video game future tech to modern day defense forces
If you’ve been paying attention over the last few years, you’ve seen a few nice runs for companies engaged in the security/military space. Patriot One (PAT.C) has done nicely with tech to sniff out security threats at crowded points of access. CAE (CAE.T) is a multi-billion dollar company working in the military sim space. Draganfly…
-
Bio-tech without the dice roll: Aequus Pharmaceuticals (AQS.V) building a solid, multi-pronged revenue earner
For the last several years, a lot of stories I’ve written on this site have been about promise. The promise of something better, cheaper, with more upside, with less downside. Promise that a team will do more, or do better, or do something – anything. Promise that, if the planets align, something big will come.…
-
Reuters journalist Pratima Desai sets up Giga Metals (GIGA.V) run and insider sell-off with fake story
UK-based commodities reporter Pratima Desai appears to have either been a useful idiot or a willing accomplice to a stock price run and subsequent insider sell-off of Canadian smallcap mining explorer Giga Metals (GIGA.V) after a false story based on unnamed sources suggesting the company was ‘in discussions’ to partnering with Tesla (TSLA.Q). LONDON (Reuters)…
-
Desert Mountain Energy (DME.V) wanted some money, the markets went all ‘No, take more! Take it all!’
Not so long ago, one of our sales guys called Desert Mountain Energy (DME.V) and said, ‘yo desert bros, we like helium, you got helium, let’s work together.’ DME politely face-palmed. ‘We don’t really have a lot of money,’ they said. ‘We’re transitioning.’ Then their stock ran from $0.70 to $1.70. Now they’ve got dollars.…
-
![Plus Products (PLUS.C) 71% costs turnaround shows legitimacy in management, anchors growth]()
Plus Products (PLUS.C) 71% costs turnaround shows legitimacy in management, anchors growth
Esteemed California cannabis gummies maker Plus Products (PLUS.C) issued quarterly financials Thursday showing a substantial turnaround as their Nevada and national CBD growth plans take hold. After a 10c per share loss in Q1, the company presented a mere 1c per share loss in Q2, with $4.3 million in revenue, despite COVID-driven slowdowns in Nevada.…
